Binding of recombinant fibrinogen mutants to platelets.

PubWeight™: 0.96‹?› | Rank: Top 15%

🔗 View Article (PMID 8276798)

Published in J Biol Chem on January 07, 1994

Authors

D H Farrell1, P Thiagarajan

Author Affiliations

1: Department of Biochemistry, University of Washington, Seattle 98195.

Articles citing this

Leukocyte engagement of fibrin(ogen) via the integrin receptor alphaMbeta2/Mac-1 is critical for host inflammatory response in vivo. J Clin Invest (2004) 2.57

Fibrinogen as a key regulator of inflammation in disease. Semin Immunopathol (2011) 2.14

Impaired platelet aggregation and sustained bleeding in mice lacking the fibrinogen motif bound by integrin alpha IIb beta 3. EMBO J (1996) 1.33

Fibrinogen stabilizes placental-maternal attachment during embryonic development in the mouse. Am J Pathol (2002) 0.96

Species differences in small molecule binding to alpha IIb beta 3 are the result of sequence differences in 2 loops of the alpha IIb beta propeller. Blood (2008) 0.92

Integrin alphaIIbbeta3:ligand interactions are linked to binding-site remodeling. Protein Sci (2006) 0.92

Functional impact of oxidative posttranslational modifications on fibrinogen and fibrin clots. Free Radic Biol Med (2013) 0.88

Dynamic regulation of fibrinogen: integrin αIIbβ3 binding. Biochemistry (2010) 0.86

Multiple sites on Streptococcus gordonii surface protein PadA bind to platelet GPIIbIIIa. Thromb Haemost (2013) 0.83

The Platelet Integrin αIIbβ3 Differentially Interacts with Fibrin Versus Fibrinogen. J Biol Chem (2016) 0.83

Fibrinogen Hershey IV: a novel dysfibrinogen with a gammaV411I mutation in the integrin alpha(IIb)beta(3) binding site. Thromb Haemost (2008) 0.79

Proteins, platelets, and blood coagulation at biomaterial interfaces. Colloids Surf B Biointerfaces (2014) 0.79

PROBING αIIbβ3: LIGAND INTERACTIONS BY DYNAMIC FORCE SPECTROSCOPY AND SURFACE PLASMON RESONANCE. Nano Life (2013) 0.78

Fibrinogen-Related Proteins in Tissue Repair: How a Unique Domain with a Common Structure Controls Diverse Aspects of Wound Healing. Adv Wound Care (New Rochelle) (2015) 0.75

Articles by these authors

Monoclonal immunoglobulin M lambda coagulation inhibitor with phospholipid specificity. Mechanism of a lupus anticoagulant. J Clin Invest (1980) 2.58

The use of the dilute Russell viper venom time for the diagnosis of lupus anticoagulants. Blood (1986) 1.98

Role of fibrinogen alpha and gamma chain sites in platelet aggregation. Proc Natl Acad Sci U S A (1992) 1.81

Immune interferon and leukocyte-conditioned medium induce normal and leukemic myeloid cells to differentiate along the monocytic pathway. J Exp Med (1983) 1.69

Lupus anticoagulants. Prog Hemost Thromb (1982) 1.56

Exposure of platelet fibrinogen-binding sites by collagen, arachidonic acid, and ADP: inhibition by a monoclonal antibody to the glycoprotein IIb-IIIa complex. Blood (1983) 1.44

Role of endothelium in thrombosis and hemostasis. Annu Rev Med (1996) 1.42

A monoclonal antibody to human platelet glycoprotein IIIa detects a related protein in cultured human endothelial cells. J Clin Invest (1985) 1.38

Fibrinogen-independent platelet adhesion and thrombus formation on subendothelium mediated by glycoprotein IIb-IIIa complex at high shear rate. J Clin Invest (1989) 1.33

P-selectin expression on platelets determines size and stability of platelet aggregates. Circulation (2000) 1.17

Adhesion of platelets to surface-bound fibrinogen under flow. Blood (1996) 1.15

Immunological specificity and mechanism of action of IgG lupus anticoagulants. Blood (1987) 1.12

Site-directed mutagenesis of the arginine-glycine-aspartic acid in vitronectin abolishes cell adhesion. J Biol Chem (1993) 1.03

P-selectin in arterial thrombosis. Z Kardiol (2004) 0.98

Microvesicle-associated tissue factor and Trousseau's syndrome. J Thromb Haemost (2007) 0.96

Procoagulant-tissue factor activity of circulating peripheral blood leukocytes. Results of in vivo studies. Thromb Res (1980) 0.96

Platelet microparticles promote platelet interaction with subendothelial matrix in a glycoprotein IIb/IIIa-dependent mechanism. Circulation (1999) 0.96

The incidence of proximal deep vein thrombosis following total knee arthroplasty in an Asian population: a Doppler ultrasound study. J Orthop Surg (Hong Kong) (2003) 0.94

Recombinant human fibrinogen and sulfation of the gamma' chain. Biochemistry (1991) 0.93

A new role for P-selectin in shear-induced platelet aggregation. Circulation (2000) 0.90

Role for sulfatides in platelet aggregation. Circulation (2001) 0.90

The platelet glycoprotein IIb/IIIa-like protein in human endothelial cells promotes adhesion but not initial attachment to extracellular matrix. J Cell Biol (1987) 0.89

Membrane proteins on human megakaryocytes and platelets identified by monoclonal antibodies. Am J Hematol (1983) 0.89

Associations of anti-beta2-glycoprotein I autoantibodies with HLA class II alleles in three ethnic groups. Arthritis Rheum (1999) 0.88

Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests. J Rheumatol (1998) 0.86

Cultured human umbilical vein endothelial cells contain a membrane glycoprotein immunologically related to platelet glycoprotein Ib. Blood (1988) 0.82

Processing of the carboxyl 15-amino acid extension in the alpha-chain of fibrinogen. J Biol Chem (1993) 0.82

Characterization of a novel autosomal dominant bleeding disorder in a large kindred from east Texas. Blood (2001) 0.82

Cholesterol sulfate: a new adhesive molecule for platelets. Circulation (2001) 0.82

Sulfatides inhibit platelet adhesion to von Willebrand factor in flowing blood. J Thromb Haemost (2003) 0.81

Atherosclerosis, autoimmunity, and systemic lupus erythematosus. Circulation (2001) 0.81

Optimization of stacked half-hitch knots for arthroscopic surgery. Arthroscopy (2001) 0.81

Biomechanical study on the effect of twisted human patellar tendon. Clin Biomech (Bristol, Avon) (2000) 0.81

Cardiolipin binding a light chain from lupus-prone mice. Biochemistry (1998) 0.80

Fibrin(ogen) peptide B beta 15-42 inhibits platelet aggregation and fibrinogen binding to activated platelets. Biochemistry (1988) 0.80

Thrombin receptor activating peptide (SFLLRN) potentiates shear-induced platelet microvesiculation. J Lab Clin Med (2000) 0.79

Erythrocyte membrane sulfatide plays a crucial role in the adhesion of sickle erythrocytes to endothelium. Thromb Haemost (2011) 0.78

Sulfatides: targets for anti-phospholipid antibodies. Circulation (2003) 0.78

A human erythroleukemia cell line synthesizes a functionally active glycoprotein IIb-IIIa complex capable of binding fibrinogen. Biochim Biophys Acta (1987) 0.78

Primary antiphospholipid antibody syndrome with mutations in the phospholipid binding domain of beta(2)-glycoprotein I. Am J Hematol (2000) 0.78

Polymorphism of beta2-glycoprotein I at codons 306 and 316 in patients with systemic lupus erythematosus and antiphospholipid syndrome. Arthritis Rheum (1999) 0.78

Mechanism of action of the lupus anticoagulant. Ann N Y Acad Sci (1981) 0.77

Monoclonal antibodies for specific cell labeling: considerations, preparations and preliminary evaluation. Int J Rad Appl Instrum B (1987) 0.76

Exposure of fibrinogen receptors on fresh and stored platelets by ADP and epinephrine as single agents and as a pair. Blood (1983) 0.76

A modified Arg-Asp-Val (RDV) peptide derived during the synthesis of Arg-Glu-Asp-Val (REDV), a tetrapeptide derived from an alternatively spliced site in fibronectin, inhibits the binding of fibrinogen, fibronectin, von Willebrand factor and vitronectin to activated platelets. Biochim Biophys Acta (1991) 0.75

Case in point. Scratch purpura of amyloid. Hosp Pract (1995) (1999) 0.75

Simultaneous presentation of multiple myeloma and acute leukemia in the absence of previous chemotherapy--report of a case. Mt Sinai J Med (1979) 0.75

Gouty arthritis in a patient with Ivemark syndrome. South Med J (1996) 0.75

Fibrinogen and prothrombin binding is enhanced to the Pro33 isoform of purified integrin alphaIIbbeta3. J Thromb Haemost (2006) 0.75

Light-chain paraproteins with lupus anticoagulant activity. Am J Hematol (1999) 0.75

Arthroscopy of the knee. Ann Acad Med Singapore (1996) 0.75

Case in point. Cerebral toxoplasmosis. Hosp Pract (1995) (2000) 0.75

Increased binding of fibrinogen to platelets in diabetes: the role of prostaglandins and thromboxane. Blood (1985) 0.75